Key result
Older age (high-risk) was associated with higher mortality than younger age (low-risk) in patients with distant metastatic (92% vs 40%) or local neck (71% vs 13%) well-differentiated thyroid cancer.
Why the study?
Does age and sex-based risk group classification predict survival in patients with surgically incurable well-differentiated thyroid carcinoma?
Cohort (n=97)
Does age and sex-based risk group classification predict survival in patients with surgically incurable well-differentiated thyroid carcinoma?
Survival in surgically incurable well-differentiated thyroid carcinoma is strongly predicted by age and sex-based risk classification.
Supports age/sex risk stratification for prognosis in incurable thyroid cancer; hypothesis-generating and should not yet change practice.
A series of 97 consecutive patients with well-differentiated thyroid carcinoma treated between 1941 and 1970 presented with distant metastatic disease or extensive nonresectable local neck disease or had residual carcinoma after thyroid resection. Men 40 years of age or younger and women 50 years of age or younger were considered at low risk for dying of disease; older patients were considered at high risk for dying of disease. Of 17 patients with distant metastatic carcinoma, 40% of younger patients in the low-risk group and 92% of older patients in the high-risk group died. Of 80 patients with unresectable or residual local neck cancer, only 13% of younger patients but 71% of older patients died. Survival related better to risk group classification as defined by age and sex than to any details of disease presentation or management. Treatment was far more successful in patients in the low-risk group.
No takes yet. Share an insight, caveat, or question.
Ricardo L. Rossi (1988) conducted a cohort in Well-differentiated thyroid carcinoma (n=97). High-risk classification (men >40 years, women >50 years) vs. Low-risk classification (men ≤40 years, women ≤50 years) was evaluated on Mortality. Older age (high-risk) was associated with higher mortality than younger age (low-risk) in patients with distant metastatic (92% vs 40%) or local neck (71% vs 13%) well-differentiated thyroid cancer.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: